Cam Gallagher

Director, Sorrento Therapeutics.

Companies

Opus Genetics, Inc.Board member Nov 9, 2020 to now¹
Zentalis Pharmaceuticals, Inc.Chief financial officer May 31, 2024 to May 31, 2024²
Zentalis Pharmaceuticals, Inc.President May 31, 2022 to May 31, 2024³
Zentalis Pharmaceuticals, Inc.Board member Apr 3, 2020 to May 31, 2024⁴
Sorrento TherapeuticsBoard member Sep 13, 2012 to Jan 24, 2014⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAROpus Genetics, Inc., Board member
2
SEC EDGARZentalis Pharmaceuticals, Inc., Chief financial officer
3
SEC EDGARZentalis Pharmaceuticals, Inc., President
4
SEC EDGARZentalis Pharmaceuticals, Inc., Board member
5
SEC EDGARSorrento Therapeutics, Board member